PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.06 and traded as high as $0.0667. PURE Bioscience shares last traded at $0.0667, with a volume of 10,650 shares changing hands.
PURE Bioscience Stock Down 4.7%
The firm’s fifty day moving average price is $0.07 and its 200 day moving average price is $0.06. The stock has a market cap of $8.67 million, a PE ratio of -2.22 and a beta of 0.16.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last posted its earnings results on Monday, June 15th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.51 million for the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
See Also
- Five stocks we like better than PURE Bioscience
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
